Search results for "next"

showing 10 items of 178 documents

Next-to-leading order Balitsky-Kovchegov equation with resummation

2016

We solve the Balitsky-Kovchegov evolution equation at next-to-leading order accuracy including a resummation of large single and double transverse momentum logarithms to all orders. We numerically determine an optimal value for the constant under the large transverse momentum logarithm that enables including a maximal amount of the full NLO result in the resummation. When this value is used the contribution from the $\alpha_s^2$ terms without large logarithms is found to be small at large saturation scales and at small dipoles. Close to initial conditions relevant for phenomenological applications these fixed order corrections are shown to be numerically important.

PhysicsLogarithmta114Nuclear Theory010308 nuclear & particles physicsFOS: Physical sciencesBalitsky-Kovchegov equation01 natural sciencesgluonsNuclear Theory (nucl-th)DipoleHigh Energy Physics - PhenomenologyHigh Energy Physics - Phenomenology (hep-ph)Quantum electrodynamics0103 physical sciencesEvolution equationquantum chromodynamicscolor glass condensateOrder (group theory)Boundary value problemResummation010306 general physicsConstant (mathematics)Saturation (chemistry)next-to-leading order corrections
researchProduct

Theoretical predictions for the direct detection of neutralino dark matter in the NMSSM

2004

We analyse the direct detection of neutralino dark matter in the framework of the Next-to-Minimal Supersymmetric Standard Model. After performing a detailed analysis of the parameter space, taking into account all the available constraints from LEPII, we compute the neutralino-nucleon cross section, and compare the results with the sensitivity of detectors. We find that sizable values for the detection cross section, within the reach of dark matter detectors, are attainable in this framework. For example, neutralino-proton cross sections compatible with the sensitivity of present experiments can be obtained due to the exchange of very light Higgses with $m_{h_1^0}\lsim 70$ GeV. Such Higgses…

PhysicsNuclear and High Energy PhysicsParticle physics010308 nuclear & particles physicsDark matterHigh Energy Physics::PhenomenologyAstrophysics (astro-ph)FOS: Physical sciencesSupersymmetryParameter spaceAstrophysics01 natural sciencesNext-to-Minimal Supersymmetric Standard ModelHigh Energy Physics - PhenomenologyHigh Energy Physics - Phenomenology (hep-ph)0103 physical sciencesNeutralinoBibliographyHigh Energy Physics::ExperimentSensitivity (control systems)010306 general physicsMinimal Supersymmetric Standard Model
researchProduct

BLM scale for the pion transition form factor

2001

The NLO Brodsky-Lepage-Mackenzie (BLM) scale for the pion transition form factor has been determined. To achieve that, a consistent calculation up to nf-proportional NNLO contributions to both the hard-scattering amplitude and the perturbatively calculable part of the pion distribution amplitude has been performed. By combining and matching the results obtained for these two amplitudes, a proper cancellation of collinear singularities has been established and the gamma5 ambiguity problem (related to the use of the dimensional regularization method) has been resolved by using the naive-gamma5 as well as the 't Hooft-Veltman (HV) schemes. It has been demonstrated that the prediction for the p…

PhysicsParticle physicsScale (ratio)High Energy Physics::LatticeNuclear TheoryHigh Energy Physics::PhenomenologyForm factor (quantum field theory)pion transition form factor; Brodsky-Lepage-Mackenzie scale; next-to-next-to-leading order; perturbative QCDFOS: Physical sciencesRenormalizationHigh Energy Physics - PhenomenologyPionHigh Energy Physics - Phenomenology (hep-ph)FactorizationStrong couplingHigh Energy Physics::ExperimentConstant (mathematics)Nuclear Experiment
researchProduct

Identification of predictive biomarkers for the efficacy of nivolumab in patients with advanced non-small cell cancer.

2019

The recent introduction of immunotherapy has disrupted the management of non-small cell lung cancer (NSCLC). Nivolumab, an antibody targeting the immune checkpoint inhibitor PD-1, has shown remarkable results in seconde-line setting after failure of standard first-line chemotherapy. However, only a quarter of patients benefits from this therapy. To date, no predictive biomarker of the therapeutic efficacy of nivolumab has been identified in a clear and consensual manner. The research for predictive biomarkers of efficacy or resistance to this treatment is, therefore, a major challenge.The emergence of high-throughput sequencing over the past decade has had a significant impact on clinical a…

Predictive modelsBiomarqueursModèles prédictifs[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyLung cancersCancers bronchiquesImmunothérapieNext-Generation sequencingImmunotherapy[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyBiomarkersSéquençage nouvelle génération
researchProduct

Prediction of a Missing Protein Expression Map in the Context of the Human Proteome Project

2015

Experimental evidence for the entire human proteome has been defined in the Human Proteome Project, and it is publicly available in the neXtProt database. However, there are still human proteins for which reliable experimental evidence does not exist, and the identification of such information has become one of the overriding objectives in the chromosome-centric study of the human proteome. With this aim and considering the complexity of protein detection using shotgun and targeted proteomics, the research community has addressed the integration of transcriptomics and proteomics landscapes. Here, we describe an analytical pipeline that predicts the probability of a missing protein being exp…

ProteomeNeXtProtMicroarrayProtein Array AnalysisProteinsShotgunGeneral ChemistryComputational biologyBiologyBioinformaticsProteomicsBiochemistryTranscriptomeGene expressionHuman proteome projectHumansTranscriptomeGeneJournal of Proteome Research
researchProduct

Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative

2017

The Mitochondrial Human Proteome Project aims at understanding the function of the mitochondrial proteome and its crosstalk with the proteome of other organelles. Being able to choose a suitable and validated enrichment protocol of functional mitochondria, based on the specific needs of the downstream proteomics analysis, would greatly help the researchers in the field. Mitochondrial fractions from ten model cell lines were prepared using three enrichment protocols and analyzed on seven different LC-MS/MS platforms. All data were processed using neXtProt as reference database. The data are available for the Human Proteome Project purposes through the ProteomeXchange Consortium with the iden…

Proteomics0301 basic medicineProteomeStandardizationComputational biologyBiologyMitochondrionProteomicsBioinformaticsBiochemistryenrichment protocol; mitochondria; Mitochondrial Human Proteome Project; standardization;Cell LineMitochondrial Proteins03 medical and health sciences0302 clinical medicineTandem Mass SpectrometryHuman proteome projectHumansProtein Interaction MapsSettore BIO/10 - BIOCHIMICAMitochondrial proteinstandardizationChromatographyLiquidNeXtProtChemistry (all)General Chemistrymitochondria030104 developmental biologyItalyenrichment protocolProteomeReference databaseMitochondrial Human Proteome Projectenrichment protocol; mitochondria; Mitochondrial Human Proteome Project; standardization; Cell Line; Chromatography Liquid; Humans; Italy; Mitochondria; Mitochondrial Proteins; Protein Interaction Maps; Proteome; Proteomics; Tandem Mass Spectrometry; Biochemistry; Chemistry (all)030217 neurology & neurosurgeryChromatography Liquid
researchProduct

THE “SALT-TASTING” NEWBORN

2021

Pseudohypoaldosteronism type 1 (PHA1) is a rare genetic disease due to the peripheral resistance to aldosterone. Clinical spectrum with neonatal onset includes salt loss, hyponatremia, hypochloraemia, hyperkalaemia, metabolic acidosis and increased plasmatic levels of aldosterone. Two forms of the disease - renal and systemic – have been described, which are genetically distinct and with wide clinical expressivity. The most severe generalized PHA1 is caused by mutations in the genes encoding for the subunits of the epithelial sodium channels (ENaC). The paper reports the case of a newborn of the first pregnancy of healthy and consanguineous Sicilian parents, with a clinical and hormonal pic…

Pseudohypoaldosteronism ENaC SCNN1A gene New splicing mutation Next generation sequencing
researchProduct

Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates

2021

Due to the widespread of the COVID-19 pandemic, the SARS-CoV-2 genome is evolving in diverse human populations. Several studies already reported different strains and an increase in the mutation rate. Particularly, mutations in SARS-CoV-2 spike-glycoprotein are of great interest as it mediates infection in human and recently approved mRNA vaccines are designed to induce immune responses against it. We analyzed 1,036,030 SARS-CoV-2 genome assemblies and 30,806 NGS datasets from GISAID and European Nucleotide Archive (ENA) focusing on non-synonymous mutations in the spike protein. Only around 2.5% of the samples contained the wild-type spike protein with no variation from the reference. Among…

RNA virusesMutation rateCoronavirusesEpidemiologyMolecular biologyT-LymphocytesMutantGene Identification and Analysismedicine.disease_causeGenomeWhite Blood CellsDatabase and Informatics MethodsSequencing techniquesMutation RateAnimal CellsDNA sequencingPathology and laboratory medicineGeneticsMutationMultidisciplinaryT CellsMicrobial MutationQRHigh-Throughput Nucleotide SequencingGenomicsMedical microbiologyVirusesSpike Glycoprotein CoronavirusMedicineSARS CoV 2PathogensCellular TypesTranscriptome AnalysisSequence AnalysisResearch ArticleNext-Generation SequencingSARS coronavirusBioinformaticsImmune CellsScienceImmunologyProtein domainSequence alignmentGenomicsGenome ViralBiologyMicrobiologyAntibodiesDNA sequencingProtein DomainsGeneticsmedicineHumansMutation DetectionPandemicsMedicine and health sciencesBlood CellsBiology and life sciencesSARS-CoV-2OrganismsViral pathogensComputational BiologyCOVID-19Cell BiologyGenome AnalysisMicrobial pathogensResearch and analysis methodsMolecular biology techniquesMutationSequence AlignmentPLOS ONE
researchProduct

Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing

2016

ABSTRACT Cells secrete extracellular RNA (exRNA) to their surrounding environment and exRNA has been found in many body fluids such as blood, breast milk and cerebrospinal fluid. However, there are conflicting results regarding the nature of exRNA. Here, we have separated 2 distinct exRNA profiles released by mast cells, here termed high-density (HD) and low-density (LD) exRNA. The exRNA in both fractions was characterized by microarray and next-generation sequencing. Both exRNA fractions contained mRNA and miRNA, and the mRNAs in the LD exRNA correlated closely with the cellular mRNA, whereas the HD mRNA did not. Furthermore, the HD exRNA was enriched in lincRNA, antisense RNA, vault RNA, …

RNA UntranslatedGene Expression ProfilingHigh-Throughput Nucleotide SequencingExosomesextracellular RNACell LineExtracellular VesiclesMicroRNAstranscriptomicsproteomicsRNA RibosomalCluster AnalysisHumansRNAexosomenext-generation sequencingRNA Messengerextracellular vesiclemicroarrayproteomicResearch Paper
researchProduct

AP5Z1/SPG4 8 frequency in autosomal recessive and sporadic spastic paraplegia

2014

Hereditary spastic paraplegias (HSP) constitute a rare and highly heterogeneous group of neurodegenerative disorders, defined clinically by progressive lower limb spasticity and pyramidal weakness. Autosomal recessive HSP as well as sporadic cases present a significant diagnostic challenge. Mutations in AP5Z1, a gene playing a role in intracellular membrane trafficking, have been recently reported to be associated with spastic paraplegia type 48 (SPG48). Our objective was to determine the relative frequency and clinical relevance of AP5Z1 mutations in a large cohort of 127 HSP patients. We applied a targeted next-generation sequencing approach to analyze all coding exons of the AP5Z1 gene. …

SPG48Nonsynonymous substitutionHereditary spastic paraplegiaGene mutationBioinformaticsDeep sequencing03 medical and health sciencesExon0302 clinical medicinetargeted next-generation sequencingGeneticsSpasticmedicineddc:610hereditary spastic paraplegiaMolecular BiologyGeneGenetics (clinical)030304 developmental biologyGenetic testingGenetics0303 health sciencesClinical Reportmedicine.diagnostic_testbusiness.industrymedicine.disease3. Good healthAP5Z1business030217 neurology & neurosurgeryMolecular Genetics & Genomic Medicine
researchProduct